Company · CIK 0002131524
Braveheart Bio, Inc.
BRVESearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$20.11−$1.28 (−6.01%)
BRVE · Last trade
- Prev close
- $21.39
- Range (30d)
- $18.58 – $21.87
On the record
Recent filings
- SCHEDULE 13D/ABRVEBraveheart Bio, Inc.0000947871-26-000860 · 33.5 KBSEC(opens sec.gov)
- 10-QBRVEQuarterly update0001628280-26-060905 · 6.2 MBSEC(opens sec.gov)
- 8-KBRVECurrent report0001628280-26-060904 · 367.4 KBSEC(opens sec.gov)
- SCHEDULE 13DBRVEBraveheart Bio, Inc.0000947871-26-000814 · 34.4 KBSEC(opens sec.gov)
- SCHEDULE 13DBRVEBraveheart Bio, Inc.0001889476-26-000004 · 38.2 KBSEC(opens sec.gov)
- SCHEDULE 13GBRVEBraveheart Bio, Inc.0001231919-26-000910 · 30.1 KBSEC(opens sec.gov)
- 8-KBRVECurrent report0001628280-26-054842 · 221.2 KBSEC(opens sec.gov)
- S-1/ABRVEBraveheart Bio, Inc.0001628280-26-050756 · 14.3 MBSEC(opens sec.gov)
- S-1BRVEIPO registration0001628280-26-048213 · 14.5 MBSEC(opens sec.gov)
Insiders
- Agarwala VineetaDirector
- Anderson Michele A.Chief Development Officer
- Andreessen Marc L10% Owner
- Bos JasperDirector
- Chimovits ErezDirector, 10% Owner
- Coloma Jason VDirector
- Forbion Growth III Management B.V.10% Owner
- Forbion Growth Opportunities Fund III Cooperatief U.A.10% Owner
- HOROWITZ BENJAMIN A10% Owner
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner
Tickers
Addresses
business
ONE LETTERMAN DR. BLDG. A, STE. A4-300
SAN FRANCISCO, CA, 94129
mailing
ONE LETTERMAN DR. BLDG. A, STE. A4-300
SAN FRANCISCO, CA, 94129
Same industry